TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
Barnekreftforeningen
Closing information (x1000 EUR)
| Closing information | 2023/12 | 2022/12 | 2021/12 |
| Turnover |
5,532
|
4,514
|
5,249 |
| Financial expenses |
1
|
0
|
0 |
| Earnings before taxes |
2,265
|
680
|
1,506 |
| Total assets |
14,106
|
12,766
|
11,973 |
| Current assets |
13,149
|
11,733
|
10,890 |
| Current liabilities |
499
|
910
|
577 |
| Equity capital |
8,169
|
6,304
|
5,935 |
| - share capital |
0
|
0
|
0 |
Financial ratios
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Solvency |
57.9%
|
49.4%
|
49.6% |
| Turnover per employee | |||
| Profit as a percentage of turnover |
40.9%
|
15.1%
|
28.7% |
| Return on assets (ROA) |
16.1%
|
5.3%
|
12.6% |
| Current ratio |
2635.1%
|
1289.3%
|
1887.3% |
| Return on equity (ROE) |
27.7%
|
10.8%
|
25.4% |
| Change turnover |
1,305
|
-460
|
5,161 |
| Change turnover % |
31%
|
-9%
|
5836% |
| Chg. No. of employees | |||
| Chg. No. of employees % |
Total value of public sale
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.